Oaktree Acquisition III Life Sciences Corp

Análisis de la acción Oaktree Acquisition III Life Sciences Corp (OACC)

$10.720

0.000 (0.00%)Al cierre

Loading chart…
Máximo
10.720
Apertura
10.720
Precio medio ponderado por volumen
10.72
Volumen
18.00
Capitalización
—
Mínimo
10.720
Importe
192.96
EV/EBITDA, TTM
0.00

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues.

Análisis de IA of Oaktree Acquisition III Life Sciences Corp (OACC)

Mantener

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

Métricas de valoración

El PER previsto actual de Oaktree Acquisition III Life Sciences Corp (OACC) es 0.00, frente a su media de 5 años de 0.00.

PER previsto

Muy infravalorado
Media 5A P/E
0.00
P/E actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
0.00
EV/EBITDA actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.06
P/S actual
0.00
Sobrevalorada
0.84
Infravalorada
-0.72

Escenarios de precio de Alphio AI para OACC

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%OACC

$12.28

Precio del escenario

B

Base

Base · 50%OACC

$11.50

Precio del escenario

B

Bajista

Bajista · 25%OACC

$10.82

Precio del escenario

Ballenas con OACC en cartera

E

Empyrean Capital Partners, LP

+ Con en carteraOACC

-3.81%

Rentabilidad a 3 meses

Preguntas frecuentes sobre OACC, respondidas por Alphio AI

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues. It operates in the Financials sector.

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar